Lumexa Imaging prices IPO at $18.50 per share

Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI) announced the pricing of its initial public offering of 25 million shares of common stock at $18.50 per share. The diagnostic imaging services provider has granted underwriters a 30-day option to purchase up to an additional 3.75 million shares.

The common stock is expected to begin trading on the Nasdaq Global Select Market under the symbol "LMRI" on December 11, 2025. The offering is expected to close on December 12, 2025, subject to customary closing conditions.

Barclays, J.P. Morgan and Jefferies are serving as joint lead book-running managers for the offering. Deutsche Bank Securities and Wells Fargo Securities are acting as book-running managers. Additional bookrunners include Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities and Raymond James.

PNC Capital Markets LLC, Academy Securities, Loop Capital Markets and R. Seelaus & Co., LLC are serving as co-managers for the transaction.

According to the press release, Lumexa Imaging operates what it describes as the second largest outpatient imaging center footprint in the United States as of September 30, 2025. The company's network spans 184 centers across 13 states and includes eight joint venture partnerships with health systems.

A registration statement on Form S-1 relating to the common stock was declared effective by the SEC on December 10, 2025. The offering is being made only by means of a prospectus, with copies available through the SEC's EDGAR database or from the lead underwriters.

You May Also Be Interested In